BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of Viyash Scientific (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 22.05 | -0.24 | -9.75 | 15.69 | 43.45 | |
| Net CashFlow From Operating Activities | -1.13 | -26.94 | 37.75 | 9.36 | 2.34 | |
| Net Cash Used In Investing Activities | -0.44 | 5.47 | -50.70 | -4.25 | 170.00 | |
| Net Cash Used From Financing Activities | 0.67 | 22.32 | 0.24 | 7.25 | -174.78 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.90 | 0.84 | -12.71 | 12.36 | -2.44 | |
| Cash And Cash Equivalents Begin of Year | 0.93 | 0.08 | 12.80 | 0.44 | 2.87 | |
| Cash And Cash Equivalents End Of Year | 0.03 | 0.93 | 0.08 | 12.80 | 0.44 |
18.02.2026
Viyash Scientif Consolidated December 2025 Net Sales at Rs 858.41 crore, up 119.65% Y-o-Y
16.02.2026
Viyash Scientif Standalone December 2025 Net Sales at Rs 341.64 crore, up 841.94% Y-o-Y
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
18.02.2026
Viyash Scientif Consolidated December 2025 Net Sales at Rs 858.41 crore, up 119.65% Y-o-Y
16.02.2026
Viyash Scientif Standalone December 2025 Net Sales at Rs 341.64 crore, up 841.94% Y-o-Y
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
11.03.2026
Granules India looks for M&A as it expands beyond the US, deepens focus on complex generics
11.03.2026
10.03.2026
Beyond the price war, Indian drug companies gearing up to win the GLP-1 retention game
10.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
22.01.2026
Dr Reddy’s stock jumps over 4% today as brokerages turn bullish after Q3 results beat estimates
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
22.01.2026
Dr Reddy’s stock jumps over 4% today as brokerages turn bullish after Q3 results beat estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities